Recent work from the lab can be found in the following references:
Wyllie, S., et al., Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis.Nature, 2018. 560: 192-197.
Wall, R.J., et al., Clinical and veterinary trypanocidal benzoxaboroles target CPSF3.Proc Natl Acad Sci U S A, 2018. 115: 9616-9621.
Corpas-Lopez, V., et al., Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani.ACS Infect Dis, 2019. 5: 111-122.